Effectivity and safety profile of tenapanor, a sodium-hydrogen exchanger isoform 3 inhibitor, as an innovative treatment for hyperphosphatemia in chronic kidney disease: A systematic review of clinical studies
| Autor: | Suciangto, William, Rasyid, Haerani, Vicente, Anastasya Angelica, Suciangto, Winny |
|---|---|
| Zdroj: | In NEFROLOGÍA November-December 2024 44(6):796-806 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|